Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

402

Citations

27

References

2012

Year

James Chih‐Hsin Yang, Jin‐Yuan Shih, Wu‐Chou Su, Te‐Chun Hsia, Chun-Ming Tsai, Sai‐Hong Ignatius Ou, Chong‐Jen Yu, Gee‐Chen Chang, Ching-Liang Ho, Lecia V. Sequist,

The Lancet Oncology

Advanced Lung DiseaseMedicineLung AdenocarcinomaPathologyLux-lung 2Cancer GeneticsPhase 2OncologyRadiation OncologyCancer TreatmentLung CancerCancer ResearchCancer Growth

References

	Year	Citations

Page 1

Page 1